Fig. 4From: Uncovering the Fate and Risks of Intravenously Injected Prussian Blue Nanoparticles in mice by an Integrated Methodology of Toxicology, Pharmacokinetics, Proteomics, and MetabolomicsProteomics and Metabolomics analysis of mouse lungs after i.v. administration of 20Â mg/kg PB NPs. (a) Venn diagram of the differentially expressed proteins in the lungs. (Blue: 7th day, Pink: 60th day). (b-c) KEGG pathway enrichment analysis of differentially expressed proteins in the lungs on the 7th day (b) and the 60th day (c). (d) OPLS-DA score plot of lung metabolomics. (e) Venn diagram of the changed metabolites in the lungs (blue: 7th day, pink: 60th day). (f-g) KEGG pathway enrichment analysis of the changed metabolites in the lungs on the 7th day (f) and the 60th day (g)Back to article page